Tips for Pharmaceutical Manufacturing Scale-Up & Tech Transfer

During a recent scale-up from clinical to commercial production of a biopharmaceutical product, a major manufacturer detected unexpected variability in the final product's potency during routine quality control testing. The…

Shortly after the scale-up of their new biologic drug, the quality control (QC) team began detecting inconsistencies in assay results. The following symptoms were reported:Click to read the full article.

Identifying the early warning signs of product quality issues is critical in a pharmaceutical environment. Symptoms may arise in various forms, often observable on the manufacturing floor or during laboratory…

Identifying symptoms related to post-approval changes is the first step in formulating an effective response. Common signals may include:Click to read the full article.

Recognizing early symptoms related to post-approval changes is crucial. Common signals may include:Click to read the full article.

When an equipment upgrade occurs, there are several symptoms or signals that may emerge, indicating a need for further investigation. Early detection of these symptoms is critical in avoiding broader…

When undergoing an equipment upgrade, various symptoms may indicate potential issues that necessitate immediate attention. Recognizing these signals promptly can mitigate risks and instigate timely interventions. Common symptoms include:Click to…

Identifying the right symptoms is crucial for an effective response to post-approval changes. Symptoms that may indicate a problem during a site transfer include:Click to read the full article.

The initial indications of a potential failure during a site transfer can manifest in various forms:Click to read the full article.

The pharmaceutical manufacturing facility was experiencing unexpected variations in a critical quality attribute (CQA) during the production of a highly regulated injectables product. The symptoms included:Click to read the full…

During the internal audit, several critical symptoms were identified on the manufacturing floor and in the quality control lab:Click to read the full article.

Identifying symptoms or signals on the production floor or in the lab is the first step to proactively managing post-approval changes. Symptoms can be detected through:Click to read the full…